CASE STUDY ANALYSIS

PULSE
PHARMACEUTICALS

Group member:
Fiza Masood
Mishal Khalid
Um-e-Aimen
Zahra Javaid
 Pakistan Pharmaceutical Industry
• 759 pharmaceutical manufacturing units
• 25 multinationals
• Meets around 70% of the country’s demand of Finished
Medicine
• Share market evenly divided between the Nationals and
the Multinationals
• The national pharma industry
• About half the population has no access to modern
medicines
Contd.
• Developing pharmaceutical market
• Pharmaceutical spending accounts for less than 1% of the
country’s GDP
• Pakistan’s pharmaceutical sector has not seen the
expected growth and dynamism
• Limited exports- falling sharply behind comparators such
as India
• Allocation inefficiency
 India Pharmaceutical Industry

• Supplies 50% of global demand for various vaccines

• 40% of generic demand in the US and 25% of all
medicine in the UK
• Supplies antiretroviral drugs to combat AIDS
• Developing pharmaceutical market
• Export stood at US$ 16.3 billion in FY20
• Medicine spending is projected to grow